Home > Publications Database > Faecal microbial transfer and complex carbohydrates mediate protection against COPD. > print

001     268848
005     20240421003703.0
024 7 _ |a 10.1136/gutjnl-2023-330521
|2 doi
024 7 _ |a pmid:38331563
|2 pmid
024 7 _ |a 0017-5749
|2 ISSN
024 7 _ |a 1468-3288
|2 ISSN
024 7 _ |a altmetric:159318801
|2 altmetric
037 _ _ |a DZNE-2024-00352
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Budden, Kurtis F
|0 0000-0002-7435-275X
|b 0
245 _ _ |a Faecal microbial transfer and complex carbohydrates mediate protection against COPD.
260 _ _ |a London
|c 2024
|b BMJ Publishing Group
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1713174705_9656
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Chronic obstructive pulmonary disease (COPD) is a major cause of global illness and death, most commonly caused by cigarette smoke. The mechanisms of pathogenesis remain poorly understood, limiting the development of effective therapies. The gastrointestinal microbiome has been implicated in chronic lung diseases via the gut-lung axis, but its role is unclear.Using an in vivo mouse model of cigarette smoke (CS)-induced COPD and faecal microbial transfer (FMT), we characterised the faecal microbiota using metagenomics, proteomics and metabolomics. Findings were correlated with airway and systemic inflammation, lung and gut histopathology and lung function. Complex carbohydrates were assessed in mice using a high resistant starch diet, and in 16 patients with COPD using a randomised, double-blind, placebo-controlled pilot study of inulin supplementation.FMT alleviated hallmark features of COPD (inflammation, alveolar destruction, impaired lung function), gastrointestinal pathology and systemic immune changes. Protective effects were additive to smoking cessation, and transfer of CS-associated microbiota after antibiotic-induced microbiome depletion was sufficient to increase lung inflammation while suppressing colonic immunity in the absence of CS exposure. Disease features correlated with the relative abundance of Muribaculaceae, Desulfovibrionaceae and Lachnospiraceae family members. Proteomics and metabolomics identified downregulation of glucose and starch metabolism in CS-associated microbiota, and supplementation of mice or human patients with complex carbohydrates improved disease outcomes.The gut microbiome contributes to COPD pathogenesis and can be targeted therapeutically.
536 _ _ |a 354 - Disease Prevention and Healthy Aging (POF4-354)
|0 G:(DE-HGF)POF4-354
|c POF4-354
|f POF IV
|x 0
536 _ _ |a 352 - Disease Mechanisms (POF4-352)
|0 G:(DE-HGF)POF4-352
|c POF4-352
|f POF IV
|x 1
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a BASIC SCIENCES
|2 Other
650 _ 7 |a COLONIC MICROFLORA
|2 Other
650 _ 7 |a DIETARY FIBRE
|2 Other
650 _ 7 |a IMMUNOLOGY
|2 Other
650 _ 7 |a INFLAMMATORY DISEASES
|2 Other
650 _ 7 |a Carbohydrates
|2 NLM Chemicals
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Mice
|2 MeSH
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a Pulmonary Disease, Chronic Obstructive: etiology
|2 MeSH
650 _ 2 |a Lung: metabolism
|2 MeSH
650 _ 2 |a Lung: pathology
|2 MeSH
650 _ 2 |a Pneumonia: etiology
|2 MeSH
650 _ 2 |a Inflammation: metabolism
|2 MeSH
650 _ 2 |a Carbohydrates: pharmacology
|2 MeSH
693 _ _ |0 EXP:(DE-2719)PRECISE-20190321
|5 EXP:(DE-2719)PRECISE-20190321
|e Platform for Single Cell Genomics and Epigenomics at DZNE University of Bonn
|x 0
700 1 _ |a Shukla, Shakti D
|0 0000-0002-5796-0171
|b 1
700 1 _ |a Bowerman, Kate L
|0 0000-0003-2339-114X
|b 2
700 1 _ |a Vaughan, Annalicia
|0 0000-0001-5890-7877
|b 3
700 1 _ |a Gellatly, Shaan L
|0 0000-0002-7361-2337
|b 4
700 1 _ |a Wood, David L A
|0 0000-0002-1001-2019
|b 5
700 1 _ |a Lachner, Nancy
|b 6
700 1 _ |a Idrees, Sobia
|0 0000-0001-8512-7593
|b 7
700 1 _ |a Rehman, Saima Firdous
|0 0000-0001-6269-355X
|b 8
700 1 _ |a Faiz, Alen
|0 0000-0003-1740-3538
|b 9
700 1 _ |a Patel, Vyoma K
|b 10
700 1 _ |a Donovan, Chantal
|0 0000-0003-4558-329X
|b 11
700 1 _ |a Alemao, Charlotte A
|b 12
700 1 _ |a Shen, Sj
|0 0000-0002-1004-1936
|b 13
700 1 _ |a Amorim, Nadia
|0 0000-0002-3619-7410
|b 14
700 1 _ |a Majumder, Rajib
|0 0000-0002-7244-6058
|b 15
700 1 _ |a Vanka, Kanth S
|0 0000-0003-3641-2499
|b 16
700 1 _ |a Mason, Jazz
|b 17
700 1 _ |a Haw, Tatt Jhong
|0 0000-0003-2315-7089
|b 18
700 1 _ |a Tillet, Bree
|0 0000-0002-0159-6649
|b 19
700 1 _ |a Fricker, Michael
|0 0000-0002-8587-1774
|b 20
700 1 _ |a Keely, Simon
|0 0000-0002-1248-9590
|b 21
700 1 _ |a Hansbro, Nicole
|0 0000-0002-2371-7990
|b 22
700 1 _ |a Belz, Gabrielle T
|0 0000-0002-9660-9587
|b 23
700 1 _ |a Horvat, Jay
|0 0000-0002-8526-0631
|b 24
700 1 _ |a Ashhurst, Thomas
|0 0000-0001-7269-7773
|b 25
700 1 _ |a van Vreden, Caryn
|0 0000-0003-4151-3470
|b 26
700 1 _ |a McGuire, Helen
|0 0000-0003-2047-6543
|b 27
700 1 _ |a Fazekas de St Groth, Barbara
|0 0000-0001-6817-9690
|b 28
700 1 _ |a King, Nicholas J C
|0 0000-0002-3877-9772
|b 29
700 1 _ |a Crossett, Ben
|0 0000-0001-5366-4554
|b 30
700 1 _ |a Cordwell, Stuart J
|0 0000-0002-0995-0171
|b 31
700 1 _ |a Bonaguro, Lorenzo
|0 P:(DE-2719)9001512
|b 32
|u dzne
700 1 _ |a Schultze, Joachim L
|0 P:(DE-2719)2811660
|b 33
700 1 _ |a Hamilton-Williams, Emma E
|0 0000-0003-4892-3691
|b 34
700 1 _ |a Mann, Elizabeth
|b 35
700 1 _ |a Forster, Samuel C
|0 0000-0003-4144-2537
|b 36
700 1 _ |a Cooper, Matthew A
|0 0000-0003-4144-2537
|b 37
700 1 _ |a Segal, Leopoldo N
|0 0000-0003-3559-9431
|b 38
700 1 _ |a Chotirmall, Sanjay H
|b 39
700 1 _ |a Collins, Peter
|0 0000-0002-5273-8213
|b 40
700 1 _ |a Bowman, Rayleen
|b 41
700 1 _ |a Fong, Kwun M
|0 0000-0002-6507-1403
|b 42
700 1 _ |a Yang, Ian A
|0 0000-0001-8338-1993
|b 43
700 1 _ |a Wark, Peter A B
|0 0000-0001-5676-6126
|b 44
700 1 _ |a Dennis, Paul G
|0 0000-0002-4895-3105
|b 45
700 1 _ |a Hugenholtz, Philip
|0 0000-0001-5386-7925
|b 46
700 1 _ |a Hansbro, Philip M
|0 0000-0002-4741-3035
|b 47
773 _ _ |a 10.1136/gutjnl-2023-330521
|g Vol. 73, no. 5, p. gutjnl-2023-330521 -
|0 PERI:(DE-600)1492637-4
|n 5
|p 751 - 769
|t Gut
|v 73
|y 2024
|x 0017-5749
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/268848/files/DZNE-2024-00352%2BSUP.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/268848/files/DZNE-2024-00352%2BSUP.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:268848
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 32
|6 P:(DE-2719)9001512
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 33
|6 P:(DE-2719)2811660
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-354
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Prevention and Healthy Aging
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-352
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms
|x 1
914 1 _ |y 2024
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Creative Commons Attribution-NonCommercial CC BY-NC 4.0
|0 LIC:(DE-HGF)CCBYNC4
|2 HGFVOC
915 _ _ |a National-Konsortium
|0 StatID:(DE-HGF)0430
|2 StatID
|d 2023-10-21
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b GUT : 2022
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-10-21
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-10-21
915 _ _ |a IF >= 20
|0 StatID:(DE-HGF)9920
|2 StatID
|b GUT : 2022
|d 2023-10-21
920 1 _ |0 I:(DE-2719)1013038
|k AG Schultze
|l Clinical Single Cell Omics (CSCO) / Systems Medicine
|x 0
920 1 _ |0 I:(DE-2719)1013031
|k Schultze - PRECISE
|l Platform for Single Cell Genomics and Epigenomics
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1013038
980 _ _ |a I:(DE-2719)1013031
980 1 _ |a FullTexts

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21